| Date Filed | Type | Description |
| 08/24/2023 |
4
| Peters Richard (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 500 shares
@ $0
Granted 2,000 options to buy
@ $3.65, valued at
$7.3k
|
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| Peters Richard (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 5,995 shares
@ $0
Granted 29,575 options to buy
@ $1.09, valued at
$32.2k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| Peters Richard (President and CEO) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.|
Txns:
| Sold 10,715 shares
@ $1.8455, valued at
$19.8k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Peters Richard (President and CEO) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 4,441 shares
@ $11.11, valued at
$49.3k
Paid exercise price by delivering 79 shares
@ $10.79, valued at
$852.4 |
|
| 07/01/2021 |
4
| Peters Richard (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 4,610 shares
@ $0
Granted 22,750 options to buy
@ $4.88, valued at
$111k
|
|
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Peters Richard (President and CEO) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.|
Txns:
| Granted 235,237 options to buy
@ $8.16, valued at
$1.9M
|
|
| 12/28/2020 |
3
| Peters Richard (President & CEO) has filed a Form 3 on YUMANITY THERAPEUTICS, INC. |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/10/2019 |
4
| Peters Richard (President and CEO) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Disposed of 25,000 options to buy
@ $10.74, valued at
$268.5k
Disposed of 225,000 options to buy
@ $4.15, valued at
$933.8k
|
|
| 12/13/2018 |
4
| Peters Richard (President and CEO) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 225,000 options to buy
@ $4.15, valued at
$933.8k
|
|
| 02/16/2018 |
4
| Peters Richard (President and CEO) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 225,000 options to buy
@ $10.74, valued at
$2.4M
|
|
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |